Filing Flows › Iradimed (IRMD) › Capital expenditures
Iradimed (IRMD) capital expenditures by quarter
Iradimed's capital expenditures were $212K in Q3 2026 (third quarter 2026), +15% from Q2 2026. Over the last 7 quarters it ranged from $185K (Q2 2026) to $3.9M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $212K | +15% | -83% |
| Q2 2026 | $185K | -61% | -93% |
| Q1 2026 | $469K | +12% | -88% |
| Q4 2025 | $417K | -67% | — |
| Q3 2025 | $1.3M | -55% | — |
| Q2 2025 | $2.8M | -28% | — |
| Q1 2025 | $3.9M | — | — |
Q3 2026 at a glance
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Iradimed's capital expenditures?
Iradimed's capital expenditures were $212K in Q3 2026 (third quarter 2026), +15% from Q2 2026.
How has Iradimed's capital expenditures changed?
Over the last 7 quarters it ranged from $185K (Q2 2026) to $3.9M (Q1 2025).